5 August 2024
Oxford Nanopore Technologies plc
(the "Company")
Admission of Ordinary Shares and Total Voting Rights
The Company confirms that, following the successful completion of a subscription by Novo Holdings A/S for new ordinary shares of £0.0001 each in the capital of the Company ("Ordinary Shares"), as announced on 31 July 2024, a total of 41,666,667 new Ordinary Shares (the "Subscription Shares") were admitted to the Official List of the Financial Conduct Authority (the "FCA") and to trading on the London Stock Exchange's main market for listed securities (the "LSE") on 5 August 2024.
Furthermore, following the successful completion of a placing of new Ordinary Shares, as announced on 31 July 2024, a total of 25,000,000 new Ordinary Shares (the "Placing Shares") were also admitted to the Official List of the FCA and to trading on the LSE on 5 August 2024.
In aggregate, the Subscription Shares and the Placing Shares comprise 66,666,667 new Ordinary Shares, which have been credited as fully paid and rank pari passu in all respects with each other and with the existing Ordinary Shares.
In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, the Company announces that as at 5 August 2024, the Company's issued share capital consisted of 940,896,164 Ordinary Shares, one class A limited anti-takeover ("LAT") share of £1.00, one class B LAT share of £1.00 and one class C LAT share of £1.00. The Company does not hold any shares in treasury. Only the Ordinary Shares are voting shares and each such Ordinary Share carries one vote per Ordinary Share. Accordingly, the total number of voting rights in the Company as at 5 August 2024 is 940,896,164. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
[ENDS]
Enquiries:
Investors
ir@nanoporetech.com
Media
media@nanoporetech.com
OxfordNanoporeTechnologies@teneo.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.